| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 65,550 | 33,395 | 5,840 | 8,961 | | Cost of Revenue | (3,073) | (10,836) | 13,910 | 21,332 | | | Gross Profit | 68,623 | 44,231 | (8,070) | (12,371) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 37,525 | 26,895 | 2,910 | 8,747 | | Non Recurring | 5,463 | 644 | 683 | 20,654 | | Others | 516 | 741 | 635 | 1,168 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 30,582 | 15,951 | (12,297) | (42,940) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 30,582 | 15,951 | (12,297) | (42,940) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 30,582 | 15,951 | (12,297) | (42,940) | | Income Tax Expense | 42 | 23 | (13) | (1,252) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,540 | 15,928 | (12,284) | (41,688) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,540 | 15,928 | (12,284) | (41,688) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,540 | $15,928 | ($12,284) | ($41,688) |
|
1.48% Nasdaq 
Income Statement
